Home > Income Statement > NGL FINECHEM

NGL FINECHEM
Revenue

    Back to Income Statement
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹339 Cr₹278 Cr₹318 Cr₹258 Cr₹15,168,639 Cr

What is the latest Revenue of NGL FINECHEM ?

The latest Revenue ratio of NGL FINECHEM is ₹339 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹339 Cr
Mar2024₹278 Cr
Mar2023₹318 Cr
Mar2022₹258 Cr
Mar2021₹15,168,639 Cr

How is Revenue of NGL FINECHEM Trending?

Years Revenue % Change
Mar2025 ₹339 Cr
21.79
Mar2024 ₹278 Cr
-12.42
Mar2023 ₹318 Cr
23.08
Mar2022 ₹258 Cr
-100.00
Mar2021 ₹15,168,639 Cr -

Compare Revenue of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹817.0 Cr 7.6% 7% -50.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,864.0 Cr -4.3% -3% -0.7% Stock Analytics
DIVIS LABORATORIES ₹168,811.0 Cr -3.3% -7.4% 34.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,352.0 Cr 1.4% 10.1% 17.9% Stock Analytics
CIPLA ₹121,260.0 Cr -4.4% -0.5% 0.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,786.0 Cr -5.2% -5.7% -5.9% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

7.6%

7%

-50.9%

SENSEX

-1.1%

-3.4%

-1.1%


You may also like the below Video Courses